<DOC>
	<DOCNO>NCT00853489</DOCNO>
	<brief_summary>The purpose study evaluate use recombinant human bone morphogenetic protein 2 ( RhBMP-2 ) compare standard ICBG treatment severe open tibia fracture critical size bone defect ( least one centimeter length compromise least 50 % circumference bone ) .</brief_summary>
	<brief_title>rhBMP-2 Versus Autograft Critical Size Tibial Defects</brief_title>
	<detailed_description>Open tibia fracture 15 % high rate healing . Those fracture heal typically treat bone hip ( iliac crest autograft ; ICBG ) . The use ICBG bone treatment delay unions/non-unions critical defect , although successful , drawback . The bone graft source limited procedure associate additional operating room time plus second incision increase risk infection , post operative pain increase hospital stay . The purpose study determine Rh-BMP2 , new bone graft substitute , least effective use bone hip ( autograft ) help promote heal open , tibia ( shin bone ) fracture . Research Questions : Primary : What relative effect rhBMP-2 versus autogenous ICBG rate union patient critical size defect follow tibial shaft fracture ? Null hypothesis # 1 : rhBMP-2 union rate use critical-sized defect ICBG . Secondary : What relative effect rhBMP-2 versus autogenous ICBG infection rate patient nonunion critical size defect follow tibial shaft fracture ? Null hypothesis # 2 : The infection rate open tibia critical-sized defect treat rhBMP-2 autogenous ICBG . What economic impact use Rh-BMP 2 tibial fracture critical size defect ? Null hypothesis # 3 : There difference economic cost treatment critical size defect use RhBMP-2 versus iliac crest bone graft .</detailed_description>
	<mesh_term>Tibial Fractures</mesh_term>
	<criteria>Patients 1865 year old open tibia fracture involve diaphysis ( patient bilateral tibia fracture require bone graft , randomize separately ) . Tibia fracture circumferential bone defect least one centimeter length compromise least 50 % circumference bone . The definitive treatment tibia fracture must intramedullary nail ( may temporary external fixation prior IM nail placement ) . Patients whose treatment plan include placement bone graft 6 16 week initial injury . Patients evidence infection clinical examination ( define active infection operative site , purulent drainage fracture evidence active osteomyelitis time bone graft ) . Patients independent living ambulation prior injury . Patients English speaking . Patients willing provide consent available followup least 12 month follow definitive surgical procedure . Patients pregnant lactate . Patients know hypersensitivity rhBMP2 bovine type I collagen . Patients history tumor , resect extant tumor , active malignancy , patient undergo treatment malignancy . Patients skeletally immature ( &lt; 18 year age radiographic evidence epiphyseal closure ) . Patients inadequate neurovascular status , e.g . high risk amputation . Patients compartment syndrome affected limb . Patients immune deficiency history autoimmune disease , Patients undergone treatment investigational therapy within month precede implantation plan within 12 month follow implantation . Patients unable return require followup visit . Patients medical comorbidities preclude treatment general anesthetic . Patient pending incarceration incarcerate . Patients active infection operative site , purulent drainage fracture evidence active osteomyelitis time bone graft . Patient intraoperative positive gram stain elevate CRP laboratory screen infection . Patient segmental defect longer 5cm length . Patients segmental defect require 60 cc bone graft . Patients require one large kit rhBMP2 time surgery . Patient 's anticipated treatment plan also include use procedure promote fracture healing , e.g . ultrasound , magnetic field electrical stimulation . Patient 's tibia fracture treat additional fixation beyond intramedullary nail , e.g . plate , wire screw . Patients pathological fracture ; know history Paget 's disease know history heterotropic calcification . Patients Glasgow Coma Scale le 15 ( less fully awake ) time informed consent . Patients previous hardware place prevents placement intramedullary nail treatment tibial shaft fracture . Patients prior use INFUSE . If patient female child bear potential : Does negative pregnancy test ( administer within 72 hour prior surgery ) ? Has agree use adequate contraception period least 1 year follow implementation rhBMP2 ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Open tibia fracture</keyword>
	<keyword>rhBMP-2</keyword>
	<keyword>critical size defect</keyword>
	<keyword>bone grafting</keyword>
</DOC>